Last Updated on by Aardvark
It’s no secret that Tilray’s cannabis sales have been dropping in Canada. In the quarter that ended Nov. 30, Tilray (TLRY) reported net revenue of $155.1M. This figure is considerably lower than consensus expectations of $170M. Tilray correlates the miss with coronavirus-related headwinds, supply-chain issues, and a lower share of the key Canadian market.
Tilray is still a market leader in Canada. And, despite the miss, the company was able to scratch out a net income of $5.7 million, compared with a loss of $34.6 million in the previous quarter.
The post Falling Cannabis Sales Point to Tilray’s (TLRY) Miss appeared first on Cannabis Stock Trades.